WO2003103675A3 - Combination treatments for purinoceptor-related disorders - Google Patents
Combination treatments for purinoceptor-related disorders Download PDFInfo
- Publication number
- WO2003103675A3 WO2003103675A3 PCT/US2003/017964 US0317964W WO03103675A3 WO 2003103675 A3 WO2003103675 A3 WO 2003103675A3 US 0317964 W US0317964 W US 0317964W WO 03103675 A3 WO03103675 A3 WO 03103675A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- purinoceptor
- related disorders
- combination treatments
- treating
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003237460A AU2003237460A1 (en) | 2002-06-06 | 2003-06-06 | Combination treatments for purinoceptor-related disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/386,769 | 2002-06-06 | ||
US38676902P | 2002-06-07 | 2002-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003103675A2 WO2003103675A2 (en) | 2003-12-18 |
WO2003103675A3 true WO2003103675A3 (en) | 2004-03-25 |
Family
ID=29736207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/017964 WO2003103675A2 (en) | 2002-06-06 | 2003-06-06 | Combination treatments for purinoceptor-related disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003237460A1 (en) |
WO (1) | WO2003103675A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1636229A4 (en) * | 2003-06-06 | 2008-07-30 | Endacea Inc | A1 adenosine receptor antogonists |
JP2007506804A (en) * | 2003-06-09 | 2007-03-22 | エンダセア, インコーポレイテッド | A1 adenosine receptor antagonist |
ES2223287B1 (en) * | 2003-08-04 | 2006-04-16 | Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea | COMPOUNDS FOR THE TREATMENT OF DEMIELINIZING AND AUTOIMMUNE DISEASES. |
CA2561383A1 (en) * | 2004-03-30 | 2005-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Prophylactic and/or therapeutic agents for chronic musculoskeletal pain |
EP2222676A4 (en) | 2007-12-21 | 2011-10-26 | Endacea Inc | A1 adenosine receptor antagonists |
WO2011094208A2 (en) * | 2010-01-26 | 2011-08-04 | Endacea, Inc. | Methods and pharmaceutical compositions for preventing and treating renal impairment |
IT202000015817A1 (en) * | 2020-07-01 | 2022-01-01 | Giampietro Iachettini | ADENOSINE FOR USE IN THE TREATMENT OF VIRAL INFECTIONS |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026728A1 (en) * | 1994-03-30 | 1995-10-12 | The Trustees Of The University Of Pennsylvania | Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
US5733916A (en) * | 1995-03-24 | 1998-03-31 | The Trustees Of The University Of Pennsylvania | Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
WO1999034803A1 (en) * | 1998-01-09 | 1999-07-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury |
WO1999038532A2 (en) * | 1998-01-28 | 1999-08-05 | Link Technology, Inc. | Methods for the prevention and treatment of fibrosis and sclerosis |
WO2002094317A1 (en) * | 2001-05-18 | 2002-11-28 | Endacea Inc. | Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists |
-
2003
- 2003-06-06 WO PCT/US2003/017964 patent/WO2003103675A2/en not_active Application Discontinuation
- 2003-06-06 AU AU2003237460A patent/AU2003237460A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026728A1 (en) * | 1994-03-30 | 1995-10-12 | The Trustees Of The University Of Pennsylvania | Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
US5733916A (en) * | 1995-03-24 | 1998-03-31 | The Trustees Of The University Of Pennsylvania | Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
WO1999034803A1 (en) * | 1998-01-09 | 1999-07-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury |
WO1999038532A2 (en) * | 1998-01-28 | 1999-08-05 | Link Technology, Inc. | Methods for the prevention and treatment of fibrosis and sclerosis |
WO2002094317A1 (en) * | 2001-05-18 | 2002-11-28 | Endacea Inc. | Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists |
Non-Patent Citations (4)
Title |
---|
NEELY C ET AL: "A1 adenosine receptor antagonist, 8-benzyl-7,(2-(ethyl(2-hydroxyethyl )amino)-ethyl)theophylline, and/or the P2X purinoceptor antagonist, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid block endotoxin-induced lung injury.", DRUG DEVELOPMENT RESEARCH, vol. 43, no. 1, January 1998 (1998-01-01), 6th International Symposium on Adenosine and Adenine Nucleotides: New Frontiers in the 3rd Millennium;Ferrara, Italy; May 19-24, 1998, pages 76, XP009016775, ISSN: 0272-4391 * |
NEELY CONSTANCE F ET AL: "A-1 adenosine receptor antagonists block ischemia-reperfusion injury of the heart.", CIRCULATION, vol. 94, no. 9 SUPPL., 1996, pages II376 - II380, XP009017123, ISSN: 0009-7322 * |
NEELY CONSTANCE F ET AL: "A-1-adenosine receptor antagonists block endotoxin-induced lung injury.", AMERICAN JOURNAL OF PHYSIOLOGY, vol. 272, no. 2 PART 1, 1997, pages L353 - L361, XP000901722, ISSN: 0002-9513 * |
STEINMETZ M ET AL: "Influence of purinoceptor antagonism on diadenosine pentaphosphate-induced hypotension in anesthetized rats.", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. UNITED STATES SEP 2000, vol. 294, no. 3, September 2000 (2000-09-01), pages 963 - 968, XP001154546, ISSN: 0022-3565 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003237460A1 (en) | 2003-12-22 |
WO2003103675A2 (en) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200631578A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury | |
TW200500375A (en) | Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae | |
WO2003094836A3 (en) | Methods and products for enhancing immune responses using imidazoquinoline compounds | |
WO2000012110A3 (en) | Use of anti(w)pressor agents for vascular remodeling in genital dysfunction | |
MX2007005570A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases. | |
IL166761A0 (en) | Use of CGRP antagonist compounds for treatment of psoriasis | |
EP1348466A3 (en) | Method for treating pain with adenosine-tetraphosphates | |
SE0002754D0 (en) | New pharmaceutical combination formulation and method of treatment with the combination | |
HUP0103078A2 (en) | Pharmaceutical compositions and methods for treating cataracts | |
HK1121936A1 (en) | Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels | |
BR9914419A (en) | Perception improvement therapy | |
NO20024646D0 (en) | Combination therapies with vasculature-damaging activity | |
WO2004038001A3 (en) | Substituted tetracycline compounds for the treatment of malaria | |
BR0200246A (en) | Combination treatment for depression | |
EA200001010A1 (en) | APPLICATION OF DEXMEDETOMIDINE FOR SEDATIVE IMPACT IN THE DEPARTMENT OF INTENSIVE THERAPY | |
EP1064966A3 (en) | Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine | |
WO2003103675A3 (en) | Combination treatments for purinoceptor-related disorders | |
EP1262197A3 (en) | Combination treatment for sleep disorders including sleep apnea | |
WO2004041191A3 (en) | Methods for the treatment, prevention and management of macular degeneration | |
TR200103418T2 (en) | Therapeutic use of melatonin. | |
BR0211855A (en) | Drug and method for treating and improving restorative sleep quality | |
MXPA04002389A (en) | Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic. | |
BR0307022A (en) | Method of treating a patient who needs analgesia | |
GB9930075D0 (en) | Medicaments | |
WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |